Landmark-based analysis of speech differentiates conversational from clear speech in speakers with muscle tension dysphonia

Keiko Ishikawa; Mary Pietrowicz; Sara Charney; Diana Orbelo

doi:10.1101/2022.10.20.22281337

ABSTRACT

This study evaluated the feasibility of differentiating conversational and clear speech produced by individuals with muscle tension dysphonia (MTD) using Landmark-Based Analysis of Speech (LMBAS). Thirty-four adult speakers with MTD recorded conversational and clear speech. Of those, 27 speakers were able to produce clear speech. The recordings of these individuals were analyzed with an open-source LMBAS program, SpeechMark®, MATLAB Toolbox ver. 1.1.2.

The mixed-effect logistic regression model indicated that the burst-onset landmark differentiated conversational speech from clear speech. The LMBAS is a potential approach for detecting the difference between conversational and clear speech in individuals with mild to moderate MTD.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of Mayo Clinic Alix School of Medicine gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes